The antineutrophil cytoplasmic antibodies (ANCA typical or not) in current medical practice

被引：4
|
作者：
Renaudineau, Y. [3 ]
Beauvillard, D. [3 ]
Segalen, I. [2 ,3 ]
Leroyer, C. [1 ]
Le Meur, Y. [2 ]
Youinou, P. [1 ]
机构：
[1] CHU Brest, Hop Cavale Blanche, Serv Pneumol, F-29609 Brest, France
[2] CHU Brest, Hop Cavale Blanche, Serv Nephrol, F-29609 Brest, France
[3] CHU Brest, Hop Morvan, Immunol Lab, F-29609 Brest, France
来源：
IMMUNO-ANALYSE & BIOLOGIE SPECIALISEE | 2011年 / 26卷 / 01期
关键词：
Antineutrophil cytoplasmic antibodies (ANCA); Vasculitis; Proteinase; 3; Myeloperoxidase (MPO); INTERNATIONAL CONSENSUS STATEMENT; WEGENERS-GRANULOMATOSIS; NECROTIZING GLOMERULONEPHRITIS; CRESCENTIC GLOMERULONEPHRITIS; SYSTEMIC VASCULITIS; DISEASE-ACTIVITY; AUTOANTIBODIES; PROTEINASE-3; NEUTROPHILS; MYELOPEROXIDASE;
D O I：
10.1016/j.immbio.2010.12.002
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
Antineutrophil cytoplasmic antibodies (ANCA) are important serological markers mostly for the small vessel systemic vasculitides. Numerous reports have established an interest for the combination of the indirect immunofluorescence (IFI) and the ELISA anti-PR3 and anti-MPO in such indication. However, conflicting results may exist between IFI and ELISA that require additional assays and such special measures are important to help and avoid clinical misinterpretation. (C) 2010 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码：27 / 34
页数：8
相关论文
共 50 条
  • [31] Diagnostic significance of antineutrophil cytoplasmic antibodies (ANCA) in systemic vasculitides
    Guillevin, L
    Jarrousse, B
    PEROXIDASE MULTIGENE FAMILY OF ENZYMES: BIOCHEMICAL BASIS AND CLINICAL APPLICATIONS, 2000, : 173 - 179
  • [32] What do antineutrophil cytoplasmic antibodies (ANCA) tell us?
    Savige, J
    Pollock, W
    Trevisin, M
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2005, 19 (02): : 263 - 276
  • [33] Antineutrophil cytoplasmic antibodies (ANCA) in rheumatoid arthritis: A prospective study
    Rother, E
    Schochat, T
    Peter, HH
    RHEUMATOLOGY INTERNATIONAL, 1996, 15 (06) : 231 - 237
  • [34] Pulmonary Involvement in Antineutrophil Cytoplasmic Antibodies (ANCA)-associated Vasculitis: The Influence of ANCA Subtype
    Mohammad, Aladdin J.
    Mortensen, Kristian H.
    Babar, Judith
    Smith, Rona
    Jones, Rachel B.
    Nakagomi, Daiki
    Sivasothy, Pasupathy
    Jayne, David R. W.
    JOURNAL OF RHEUMATOLOGY, 2017, 44 (10) : 1458 - 1467
  • [35] ANTINEUTROPHIL ANTIBODIES (ANCA)
    FEIGHERY, C
    JACKSON, J
    IRISH JOURNAL OF MEDICAL SCIENCE, 1991, 160 (03) : 91 - 92
  • [36] Antineutrophil cytoplasmic antibodies (ANCA) testing: detection methods and clinical application
    Sinico, R. A.
    Radice, A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (02) : S112 - S117
  • [37] DESCRIPTION OF A COHORT OF PATIENTS WITH SYSTEMIC SCLEROSIS AND ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES (ANCA)
    Jeria, Sycille
    Park, Hyesang
    Garcia-Guillen, Andrea
    Lobo, David
    Laiz, Ana
    Magallares, Berta
    Moya, Patricia
    Millan Arciniegas, Ana Milena
    Diaz-Torne, Cesar
    Fernandez-Sanchez, Susana P.
    Corominas, Hector
    Castellvi, Ivan
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 2096 - 2097
  • [38] ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES (ANCA) - THEIR DETECTION AND SIGNIFICANCE - REPORT FROM WORKSHOPS
    SAVIGE, JA
    DAVIES, DJ
    GATENBY, PA
    PATHOLOGY, 1994, 26 (02) : 186 - 193
  • [39] Antineutrophil cytoplasmic antibodies (ANCA)-associated crescentic glomerulonephritis and propylthiouracil therapy
    Yuasa, S
    Hashimoto, M
    Yura, T
    Sumikura, T
    Takahashi, N
    Shoji, T
    Uchida, K
    Fujioka, H
    Kihara, M
    Matsuo, H
    NEPHRON, 1996, 73 (04): : 701 - 703
  • [40] ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES (ANCA) IN INFLAMMATORY BOWEL DISEASES (IBD) IN THE CHINESE
    SUNG, JY
    CHAN, KL
    LAWTON, J
    LEUNG, JCK
    LAI, KN
    GASTROENTEROLOGY, 1993, 104 (04) : A786 - A786
12345